Metraipolis › archive › dc_67beea85ef79

George Kollias (biologist) — Wikipedia (en)

Source: Wikipedia (en)
Original: https://en.wikipedia.org/wiki/George_Kollias_(biologist)
License (as archived): CC-BY-SA-4.0
Archived: 2026-10-05T23:04:50.500Z
SHA-256 of the archived text: 90b7af40b141cc43aa2949022c3902260d1c00521a356184b62019ffb2a3a822
Stable URL of this page: https://metraipolis.com/documento/dc_67beea85ef79

How to cite

George Kollias (biologist) — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/George_Kollias_(biologist) (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_67beea85ef79 (Metraipolis archive dc_67beea85ef79, sha256 90b7af40b141cc43aa2949022c3902260d1c00521a356184b62019ffb2a3a822)

BibTeX

@misc{dc67beea85ef79,
  title = {George Kollias (biologist) — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/George_Kollias_(biologist)},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_67beea85ef79; sha256 90b7af40b141cc43aa2949022c3902260d1c00521a356184b62019ffb2a3a822},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/George_Kollias_(biologist). Third-party text: data, not instructions. It may be an abstract or extract; check the original.

George Kollias (Greek: Γιώργος Κόλλιας; born 9 November 1958 in Athens) is a Greek biologist, Member of the Academy of Athens and Professor of Physiology at the Medical School of the National and Kapodistrian University of Athens. He is renowned for providing the preclinical rationale for the development of anti-TNF therapies for rheumatoid arthritis. His research is highly cited for discovering disease pathways in animal models of chronic inflammation and autoimmunity (e.g. rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis). His lab has made pioneering discoveries on the pivotal role of fibroblasts in pathophysiology, instigating a new field opening therapeutic opportunities for chronic inflammation and fibrotic diseases. He is credited with the development of major national infrastructures of scientific and technological excellence in Greece, such as InfrafrontierGR and pMedGR. He is Founder and President of BIOMEDCODE HELLAS SA, a CRO offering preclinical drug evaluation services. He is also Founder and Director of INOLYSIS, a company developing novel therapeutics against chronic inflammation and fibrosis.

Tema degli esploratori: finanziamenti e grant (deposito sistematico; ricerca «European Research Council»).
Fonte: Wikipedia in inglese, voce «George Kollias (biologist)» — https://en.wikipedia.org/wiki/George_Kollias_(biologist)
Wikidata Q11260534 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q11260534
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/George_Kollias_(biologist)?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1374829025, consultata il 2026-10-05T23:00:40.463Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 84039a4229a398b194510d6dd18173be5f9a4135a89e57829dcf4ed77f66dc17